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Estrogen‑related receptor 
alpha (ERRα) is a key regulator 
of intestinal homeostasis 
and protects against colitis
Allan Tran1, Charlotte Scholtes2, Mario Songane3, Claudia Champagne3, Luc Galarneau4, 
Marie‑Pier Levasseur2,5, Nassima Fodil5, Catherine Rosa Dufour2, Vincent Giguère2,3,5,7 & 
Maya Saleh1,3,6,7*
The estrogen‑related receptor alpha (ERRα) is a primary regulator of mitochondrial energy 
metabolism, function and dynamics, and has been implicated in autophagy and immune regulation. 
ERRα is abundantly expressed in the intestine and in cells of the immune system. However, its role in 
inflammatory bowel disease (IBD) remains unknown. Here, we report a protective role of ERRα in the 
intestine. We found that mice deficient in ERRα were susceptible to experimental colitis, exhibiting 
increased colon inflammation and tissue damage. This phenotype was mediated by impaired 
compensatory proliferation of intestinal epithelial cells (IEC) following injury, enhanced IEC apoptosis 
and necrosis and reduced mucus‑producing goblet cell counts. Longitudinal analysis of the microbiota 
demonstrated that loss of ERRα lead to a reduction in microbiome α‑diversity and depletion of healthy 
gut bacterial constituents. Mechanistically, ERRα mediated its protective effects by acting within the 
radio‑resistant compartment of the intestine. It promoted disease tolerance through transcriptional 
control of key genes involved in intestinal tissue homeostasis and repair. These findings provide 
new insights on the role of ERRα in the gut and extends our current knowledge of nuclear receptors 
implicated in IBD.
Inflammatory bowel diseases (IBD) are a group of chronic idiopathic inflammatory disorders of the gastrointes-
tinal tract characterized by alternating phases of relapse and remission. The two main forms of IBD are Crohn’s 
disease (CD) and ulcerative colitis (UC). While the etiology of IBD remains elusive, it is thought to arise from an 
inappropriate immune response to the intestinal microbiota in genetically susceptible individuals. The monolayer 
of the intestinal epithelium acts as a defensive barrier that ensures the segregation of luminal contents from the 
mucosal immune system. Defects in epithelial integrity or function contribute to dysregulated mucosal immunity, 
associated with perturbations in the intestinal microbiome. IBD is characterized by loss of microbiota bacterial 
diversity, expansion of Proteobacteria (e.g. increase in Escherichia spp.) and depletion of firmicutes (e.g. loss of 
Faecalibacterium prausnitzii)1. Despite inter-individual variations, IBD-associated gut dysbiosis is accompanied 
by consistent metabolic alterations, notably a reduction in short chain fatty acids (SCFAs), secondary bile acids 
and  acylcarnitines2, which link microbiota dysbiosis to host metabolism, particularly fatty acid oxidation (FAO) 
in the mitochondria.
A fine-tuned regulation of the turnover of the gut epithelium and maintenance of immunological tolerance 
are tightly regulated by mitochondrial function. Mitochondrial metabolism regulates intestinal homeostasis by 
orchestrating intestinal epithelial cells (IEC) regeneration and  differentiation3. Additionally, the mitochondria 
serve as structural and functional hubs for innate immunity  signaling4. Quality control of the mitochondria and 
energy metabolism are contingent on mitochondrial biogenesis and dynamics through fission and fusion, the 
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mitochondrial unfolded protein response (mt-UPR), and the autophagy-dependent degradation of damaged 
mitochondria, known as  mitophagy5. Defects in these pathways are linked to IBD in genetic-association and 
functional  studies6,7. Mitochondrial abnormalities, such as a swollen structure and irregular cristae have been 
observed in the enterocytes of IBD patients, and higher mitochondrial DNA levels were found in their plasma 
and  feces8. Moreover, IBD patients have an energy deficit, with lower ATP levels in their intestinal  mucosa9 
and a dysfunctional mitochondrial respiratory chain complex  activity10,11. Similarly, mice with colitis exhibit 
downregulated mitochondrial biogenesis, impaired mitochondrial function and structure, and oxidative  stress12. 
Defects in autophagy and mitophagy are also associated with IBD, by impacting IEC survival and function, anti-
microbial peptide production, bacterial handling, reactive oxygen species (ROS) levels and immune responses 
to the microbiota.
Several nuclear receptors (NRs) regulate gut physiology and counter intestinal  inflammation13, suggesting that 
the use of their ligands/agonists could benefit IBD patients. Concordantly, the Peroxisome proliferator-activated 
receptor (PPAR)γ agonist, rosiglitazone, has shown some efficacy in the treatment of mild to moderately active 
UC in a phase 2 clinical  trial14. The estrogen-related receptor α (ERRα; NR3B1), a member of the orphan NR 
family, is a central regulator of mitochondrial energy metabolism, mitochondrial biogenesis and  dynamics15. 
ERRα is expressed ubiquitously in all cells and  tissues16, particularly in tissues with high oxidative capacity 
including the intestine, and acts at the intersection of cellular metabolism, oncogenesis, and  immunity17–21. 
ERRα governs all aspects of mitochondrial function by regulating the expression of nuclear-encoded mito-
chondrial  proteins22. Notably, it is required for the transport of acylcarnitines into the mitochondrial matrix for 
FAO, through transcriptional regulation of carnitine/acylcarnitine translocase (CACT)23. ERRα also regulates 
autophagy and  mitophagy24,25. The transcriptional activity of ERRα is dependent on the co-activators PGC-1α 
and PGC-1β26–29. PGC-1α, in particular, controls IEC fate by instructing a glycolytic-to-oxidative gradient along 
the crypt-villus  axis30. Importantly, its levels are reduced in IBD and in experimental models of colitis, and its 
IEC-specific deletion in mice (PGC-1α ΔIEC) results in increased susceptibility to experimental colitis induced 
by dextran sodium sulfate (DSS)12.
Taken its role in energy metabolism, autophagy and immunity, and its close interaction with PGC-1α, we 
hypothesized that ERRα is critical in intestinal homeostasis. Here, we show that ERRα knockout mice (Esrra−/−) 
phenocopied PGC-1α deficiency in colitis, exhibiting a heightened disease severity, increased intestinal inflam-
mation, loss of goblet cells and microbiota dysbiosis. Our study reveals an important role for ERRα in intestinal 
homeostasis, highlighting its potential as a therapeutic target in IBD.
Results
Esrra−/− mice exhibited heightened susceptibility to experimental colitis associated with 
impaired intestinal epithelial regeneration and increased cell death. To evaluate the role of 
ERRα in intestinal homeostasis, we first examined its gene expression across 54 tissues obtained from the Gen-
otype-Tissue Expression (GTEx) portal (https:// gtexp ortal. org). This analysis revealed that ESRRA expression is 
highly enriched in normal human colon tissue (Fig. S1a). Furthermore, among the 3 ESRR isoforms, ESRRA was 
the predominant isoform expressed in the colon, as assessed in the transverse and sigmoid parts of this tissue 
(Fig. S1b). To explore the impact of ERR perturbation on colitis in an experimental in vivo model, we subjected 
wild-type (WT) and Esrra−/− mice to 3% DSS in their drinking water for 12 days. Whereas there was no differ-
ence in mouse survival in WT or Esrra−/− untreated mice, sustained DSS treatment led to significantly height-
ened mortality in Esrra−/− mice compared to WT controls (Fig. 1a). Next, we treated WT or Esrra-/ mice with 
3% DSS for 5 days, followed by 3 days of regular drinking water to explore their response to acute DSS-induced 
injury and follow-up recovery. Treated Esrra−/− mice were markedly more susceptible to acute DSS-induced 
colitis than WT mice, as evidenced by increased body weight loss (Fig. 1b), shortened colon length at endpoint 
(day 8) (Fig. 1c,d) and more severe disease activity index (DAI) scores, which were based on a combined score 
of body weight loss, stool consistency, and visual rectal bleeding (Fig. 1e). Histological analysis of colon tissue 
sections revealed greater tissue injury and loss of colon crypt architecture in treated Esrra−/− mice compared to 
WT mice (Fig. 1f). These phenotypes were not observed in vehicle-treated mice, as Esrra−/− mice had similar 
survival, changes in body weight, colon length and an intact colon histology compared to WT mice (Fig. 1a–f). 
We next used ImageScope to quantify the extent of colon tissue damage, by measuring the length of healthy, 
damaged or fully eroded sections and expressing them as a percentage of the full colon length. Damaged crypts 
were defined as disorganized or incomplete crypts, whereas fully eroded sections were defined by the absence of 
crypts. Quantitatively, ~ 90% of the colon tissue was damaged or eroded in Esrra−/− mice on day 8 post-DSS treat-
ment compared to ~ 30% in WT mice (Fig. 1g). These results suggested that ERRα expression protects against 
DSS-induced colitis.
To investigate the underlying mechanisms, we first evaluated the extent of cell death in the colon of DSS-
treated animals. Immunofluorescence staining of colon tissue sections with anti-cleaved caspase-3 antibodies and 
TUNEL showed that loss of ERRα led to increased numbers of early apoptotic (cleaved caspase-3), late apoptotic 
(double positive) and necrotic (TUNEL) cells (Fig. 2a,b). Consistently, immunoblot analysis of colon homogen-
ates showed increased cleaved caspase-3 and phosphorylated RIPK1, markers of apoptosis and necroptosis, in the 
colon of Esrra−/− mice relative to WT mice (Fig. 2c). Second, we sought to examine the impact of ERRα deletion 
on colonic epithelial regeneration following tissue damage with DSS. Immunofluorescence staining of colon 
tissue sections on day 8 post-DSS with anti-PCNA (proliferating cellular nuclear antigen) antibodies revealed 
markedly reduced IEC compensatory proliferation in the crypts of Esrra−/− mice compared to WT mice, sug-
gesting a role of ERRα in tissue restitution (Fig. 2d,e). Last, we evaluated the number of goblet cells, a specialized 
IEC type responsible for mucus production and depleted in inflammatory contexts such as in IBD  patients31. 
Immunofluorescence staining of colon tissue sections on day 8 post-DSS with anti-mucin-2 (MUC-2) antibodies 
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Figure 1.  Esrra−/− mice exhibited heightened susceptibility to experimental colitis. (a) Survival of untreated 
(NT) WT (n = 8) and Esrra−/− (n = 8) mice and WT (n = 16) and Esrra−/− (n = 12) mice after 3% DSS treatment. 
Statistical significance was performed using log-rank (Mantel-Cox) test, ***p < 0.001. (b) Body weight loss (%) 
of untreated (NT) WT (n = 7) and Esrra−/− (n = 10) mice and WT (n = 22) and Esrra−/− (n = 28) mice after 3% 
DSS treatment. Statistical significance was performed using Student’s t-test, *p < 0.05, ***p < 0.001. (c) Colon 
lengths of untreated (NT) WT (n = 21) and Esrra−/− (n = 21) mice and WT (n = 21) and Esrra−/− (n = 28) mice 
after 3% DSS treatment. Each symbol represents 1 mouse; the horizontal line represents the mean + /- SEM. 
Statistical significance was performed using Student’s t-test, ****p < 0.0001. ns, not significant. (d) Representative 
photographs of colon and cecum from untreated (NT) WT and Esrra−/− mice or mice on day 8 after 3% DSS 
treatment. (e) Disease activity index (DAI) of untreated (NT) WT (n = 7) and Esrra−/− (n = 10) mice and 3% 
DSS-treated WT (n = 4) and Esrra−/− (n = 5) mice after 6 and 7 days of water or 3% DSS treatment. Statistical 
significance was performed using Student’s t-test, *p < 0.05, ***p < 0.001. (f) Representative Hematoxylin and 
eosin (H&E) staining of colon sections derived from untreated (NT) WT or Esrra−/− mice or mice on day 8 
following 3% DSS treatment (magnification ×100, with 4 × zoom). (g) Intestinal tissue damage and erosion 
were quantified by measuring the length of healthy, damaged, eroded sections, and each category expressed as 
a percentage of colon length. Data represent the mean ± SEM. Statistical analysis was performed using two-way 
analysis of variance (ANOVA, *p < 0.05, ****p < 0.0001). ns, not significant.
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showed a more severe reduction in the number of goblet cells in DSS-treated Esrra−/− mice compared to WT 
mice (Fig. 2f,g). Collectively, our data indicate that ERRα sustains IEC survival and promotes IEC proliferation 
following injury, and that these homeostatic responses are required for disease tolerance.
Loss of ERRα results in exacerbated DSS‑induced colonic inflammation and alterations in 
microbiota diversity and composition. To assess the extent of colonic inflammation, we performed 
qRT-PCR quantification of inflammatory mediators in the colon of untreated or DSS-treated animals, as well as 
immunofluorescence staining of T cells (anti-CD3), B cells (anti-CD19), macrophages (anti-F4/80) and granulo-
cytes (anti-Ly6G) on colon tissue sections from DSS-treated mice at endpoint. We observed exacerbated expres-
sion of inflammatory mediators in colon homogenates of DSS-treated Esrra−/− mice compared to WT controls, 
whereas no differences were observed in untreated mice between the two genotypes (Fig. 2h). We also observed 
a significant increase in the infiltration of T cells and granulocytes (Fig. 2i–k) and a trend towards increased 
infiltration of B cells and macrophages (Fig. 2l–n) in the colon of Esrra−/− mice compared to WT mice on day 8 
post-DSS.
We next wished to explore the role of ERRα in the regulation of the host-microbiota crosstalk during the 
course of colitis. We thus characterized the bacterial microbiota by 16S rRNA sequencing of fecal pellets col-
lected at baseline (day 0) and longitudinally on days 2, 4, 6, and 7 post-DSS in the two genotypes. We elected 
to examine early time points (e.g. day 2) to determine whether microbiota changes preceded the visual signs of 
colitis i.e. diarrhea, rectal bleeding, and weight loss (generally observed around day 5 post-DSS). This analysis 
showed no significant differences in microbiota composition between WT and Esrra−/− mice at baseline (day 0). 
However, a quick decrease in microbial α-diversity was observed as early as day 2 post-DSS treatment in both 
genotypes, but that was more severe in Esrra−/− mice (Fig. 3a). Furthermore, the DSS-induced shift in microbiota 
composition was markedly influenced by ERRα expression. This was manifested by significant differences in 
abundance of several genera, according to the ANCOM test, including Akkermansia, Ruminoccocus, Oscillospira, 
Odoribacter, Desulfovibrio, Dehalobacterium and Sutterella between the two mouse genotypes (Fig. 3b). As early 
as day 2 post-DSS, the levels of A. muciniphila, a bacterium associated with a healthy gut, collapsed in both 
genotypes. However, whereas its levels recovered in WT animals by day 6 post-DSS, they remained depleted 
in Esrra−/− mice (Fig. 3b,c). Esrra−/− mice had significantly higher levels of Sutterella on day 2 post-DSS, but its 
levels remained blunted compared to WT mice throughout the course of the treatment (Fig. 3d). As observed in 
IBD, Proteobacteria expanded in Esrra−/− mice as colitis progressed (Fig. 3e). Together, our results indicate that 
loss of ERRα expression elicits inflammatory responses in the colon and impacts microbial composition prior 
to the establishment of overt colitis.
Expression of ERRα in the radio‑resistant compartment mediates resistance to DSS‑induced 
colitis. To determine the cellular compartment in the intestine requiring ERRα expression for countering 
colitis, bone marrow chimeras were generated by the reconstitution of lethally irradiated mice with bone mar-
row derived from donor mice of the same or opposite genotype. Twelve weeks after reconstitution, the four 
chimeric groups were treated with DSS. Our results showed that Esrra−/− mice remained highly susceptible to 
colitis regardless of their bone marrow transplant genotype (WT → Esrra−/− or Esrra−/− → Esrra−/−). Of note, 
Figure 2.  Loss of ERRα results in impaired intestinal epithelial regeneration, increased cell death and 
exacerbated DSS-induced colonic inflammation. (a) Immunofluorescence images of colon sections from 
WT and Esrra−/− mice on day 8 after 3% DSS treatment stained with antibodies against cleaved caspase-3 
and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling), and Hoechst to label nuclei. 
Zoomed images correspond to boxed regions. (b) Quantification of cleaved caspase-3 positive, TUNEL positive, 
and double positive cells, per area  (mm2) on day 8 following DSS treatment is shown. Data represent the 
mean ± SEM of 3 mice/genotype. Statistical analysis was performed using Student’s t-test, *p < 0.05. (c) Western 
blots depicting cleaved caspase-3, phosphorylated RipK1, and beta-actin levels in colon homogenates from 6 
WT and 6 Esrra−/− mice on day 8 after 3% DSS treatment. (d) Immunofluorescence was performed on colon 
sections derived from WT and Esrra−/− mice on day 8 after 3% DSS treatment stained with antibodies against 
proliferating cellular nuclear antigen (PCNA) to mark dividing cells, E-cadherin to mark intestinal epithelial 
cells (IECs), and Hoechst to label nuclei. (e) The quantification of  PCNA+ cells per crypt on day 8 following 3% 
DSS treatment is shown (5–10 crypts were scored/mouse). Data represent the mean ± SEM of n = 3–4 mice/
genotype. Statistical analysis was performed using Student’s t-test, **p < 0.001. (f) Immunofluorescence images of 
colon sections from WT and Esrra−/− mice on day 8 following 3% DSS treatment stained with antibodies against 
MUC-2. (g) The quantification of MUC-2 positive cells/mm2 on day 8 following 3% DSS treatment is shown. 
Data represent the mean ± SEM of 3 mice/genotype. Statistical analysis was performed using Student’s t-test, 
**p < 0.01. ns, not significant. (i) Immunofluorescence staining was performed on colon sections derived from 
WT or Esrra−/− mice on day 8 after 3% DSS treatment. The staining was with anti-CD3 antibodies to mark T 
cells, anti-Ly6G antibodies to mark granulocytes, and Hoechst to label nuclei. (j,k) Quantification of CD3 + and 
Ly6G + cells/area  (mm2) on day 8 following 3% DSS treatment is shown. Data represent the mean ± SEM 
of n = 3–4 mice/genotype. Statistical analysis was performed using Student’s t-test, *p < 0.05, **p < 0.01. (l) 
Immunofluorescence staining was performed on colon sections derived from WT or Esrra−/− mice on day 8 after 
3% DSS treatment. The staining was with anti-CD19 antibodies to mark B cells, anti-F4/80 antibodies to mark 
macrophages, and Hoechst to label nuclei. (m,n) Quantification of CD19+ and F4/80+ cells/area  (mm2) on day 
8 following 3% DSS treatment is shown. Data represent the mean ± SEM of n = 3–4 mice/genotype. Statistical 
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the transplant of WT bone marrow did not improve the severely blunted colon length of Esrra−/− recipient 
mice (Fig. 4a,b) but slightly improved colon histology (Fig. 4c,d). Reciprocal transplantation of bone marrow 
from Esrra−/− mice did not transfer the enhanced colitis susceptibility to WT mice (Esrra−/−→WT), which were 
equivalent to WT controls (WT→WT), as observed at the level of colon length (Fig. 4a,b) and histopathology 
(Fig. 4c,d). These findings indicate that ERRα acted primarily in the radio-resistant compartment of the colon to 
mediate its protective effects against DSS-induced colitis.
The ERRα‑dependent colon and IEC transcriptomes in colitis. To explore the ERRα transcriptional 
program in colitis, we first performed bulk RNA sequencing (RNAseq) of the colon from WT or Esrra−/− mice on 
day 8 post-DSS. The genes regulated by ERRα at endpoint are depicted in a volcano plot (Fig. 5a) and a heatmap 
(Fig. 5b). Other than Esrra (gene for ERRα), a total of 46 genes, implicated in diverse biological processes includ-
ing immunity, metabolism, and wound healing, were identified to be differentially expressed (DE) between the 
two genotypes (FDR < 0.1). These included direct ERRα transcriptional targets (e.g. Rhdh9, Aldh1al, Rarres, 
Agpat2, Got1, Ndufa4, Pon1, Gpr55, Prr5l, Grb2, Grip2, Scnn1b, Bhmt, Bhmt2 and Il9r)32,33. Several genes of the 
humoral immune response were downregulated in Esrra−/− mice, including immunoglobulin genes and C4bp, a 
regulator of the complement cascade. In contrast, expression of the chemokine Ccl20 and regnase-1 (Zc3h12a), a 
negative regulator of TLR and IL-1R mediated cytokine  production34, were upregulated in Esrra−/− mice. Several 
metabolic genes were also DE between the two genotypes. These included ndufa4 (oxidative metabolism), agpat2 
(lipid metabolism), got1 (amino acid and urea metabolism), bhmt and bhmt2 (homocysteine metabolism), hkdc1 
(glucose metabolism), lyd (hormone metabolism), dmgdh (choline metabolism) and rdh9 and ald1a1 (retinoic 
acid metabolism). The remaining DE genes included plet1, involved in wound healing, and pon1 encoding Par-
aoxonase 1, an antioxidant downregulated in  IBD35.
Based on ERRα’s protective role in the radio-resistant compartment of the intestine, the abundance of IECs 
compared to other radio-resistant cells, and the key role of the ERRα co-activator PGC1α in  IECs12, we next 
decided to explore the ERRα-dependent IEC transcriptome. Further to avoid adaptation mechanisms arising in 
Esrra−/− mice, and as a clinically relevant intervention, we opted to study the effects of acute inhibition of ERRα 
Figure 3.  ERRα deficiency leads to alterations in fecal microbiota diversity and composition. (a) Analysis 
of the microbiome alpha diversity in the fecal pellets of WT mice or Esrra−/− mice collected at baseline (day 
0—untreated) or at different time points after 3% DSS treatment. Kruskal–Wallis for all groups, p < 0.01. 
(b) Bacterial genera (the phylum name is indicated under the genus name) with significant differences in 
abundance levels (ANCOM test) in the fecal pellets of WT mice versus Esrra−/− mice, day 6 is illustrated. 
Differences in operational taxonomic units (OTUs) between WT and Esrra−/− mice at different time points in 
the DSS experiment in Akkermansia muciniphila (c), Sutterella (d), and Proteobacteria (e). Data represent the 
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Figure 4.  Expression of ERRα in the radio-resistant compartment mediates resistance to DSS colitis. (a) Colon 
length of bone marrow chimera mice on day 8 following DSS treatment. Data represent the mean ± SEM of 
n = 8–10 mice. Statistical analysis was performed with Student’s t-test, *p < 0.05, **p < 0.01. ns, not significant. 
(b) Representative photographs of colon and cecum on day 8 following DSS treatment. (c) Representative 
Hematoxylin and eosin (H&E) staining of colon sections derived from bone marrow chimera mice on day 
8 following DSS treatment. (d) Intestinal tissue damage and erosion of bone marrow chimera mice on day 
8 following DSS treatment, quantified by measuring the length of healthy, damaged, eroded sections, and 
expressed as a percentage of colon length. Data represent the mean ± SEM of 8–10 mice/genotype. Statistical 
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with an inverse agonist, named Compound 29 (C29)36 in WT mice. As observed in Esrra−/− mice, pre-treatment 
of WT mice with C29 led to enhanced colitis severity on day 8-post DSS administration compared to vehicle-
treated mice (Fig. 5c–e). To maximize the discovery of genes involved in intestinal homeostasis or disease induc-
tion, we performed the IEC RNAseq analysis at an earlier time point following DSS treatment (day 2). A total of 
62 DE genes were found between C29 and vehicle-treated mice (FDR < 0.1) (Fig. 5f–h), including direct ERRα 
transcriptional targets. Among these were genes that play a role in lipid metabolism (Fig. 5i), many of which have 
been previously implicated in  IBD37,38. These included Apoc3, Apoa1, Scd1, components of lipoproteins (Apoc1 
and Apoa5), Slc27a5, involved in fatty acid elongation and synthesis, and Phyh, responsible for alpha-oxidation 
of peroxisomes. These lipid metabolism genes were found downregulated following acute inhibition of ERRα. 
C29 also impacted genes involved in immunity, blood coagulation, amino acid metabolism, protein transport, 
cell adhesion and spreading, and RNA synthesis. Immune-related genes downregulated by ERRα inhibition 
included Pigr, C4b, and Itih4. The remaining downregulated genes included the organic solute carrier Slc38a4 
known to transport amino acids, Serpinc1, Serpine1, and Plg, known regulators of the blood coagulation cascade, 
and Vtn, involved in mucosal wound healing. Collectively, our data reveal a critical role of ERRα in intestinal 
homeostasis through a transcriptional program regulating several metabolic and immunity-related genes, with 
demonstrated links to IBD as discussed below.
Discussion
ERRα controls a wide transcriptional network pertaining to cellular energy metabolism, mitochondrial function, 
autophagy and wound healing, among  others32,33,39. As dysfunctional mitochondria release danger-associated 
molecular patterns (DAMPs), including ROS, oxidized mtDNA and cardiolipin, it is plausible that the accumula-
tion of these DAMPs in ERRα-deficient mice promotes IEC death and inflammatory tissue damage. Indeed, ROS 
production is increased in experimental colitis and correlates with disease  severity12. ERRα has been reported to 
induce anti-oxidant protective  genes40, and decreased antioxidant capacity has been described in IBD  patients41. 
We have observed a decrease in the expression of pon1, a gene linked to IBD that normally mediates both anti-
oxidant and anti-inflammatory activities in  IECs42. The severe colitis phenotype associated with ERRα loss may 
also be due to a failure to provide adequate energy supply to sustain colonocyte survival and barrier integrity, 
as maintenance of tight junctions (TJ) between IECs is energy  dependent43. Lipid metabolism, in particular 
apoa1 gene activity, supports TJ recovery after  damage44. ERRα may also be exerting its protective role through 
autophagy, which is central for intestinal  homeostasis7,45,46.
Although the exacerbated inflammation in Esrra−/− mice could be secondary to their marked epithelial tis-
sue damage, the inflammatory infiltrates and mediators found upregulated in Esrra−/− mice are implicated in 
IBD pathogenesis. In particular, IL-6 levels are associated with disease activity in IBD patients and the risk of 
 relapse47,48. Similarly, iNOS overexpression and increased NO production are linked to IBD disease  severity49. 
Our results show that ERRα-deficiency resulted in exacerbated iNOS induction in the colon of colitic mice. NO 
impairs beta-oxidation in IECs leading to oxygen accumulation in the intestinal lumen and microbiota dysbiosis, 
including the expansion of pathogenic Enterobacteriaceae of the Proteobacteria  phylum50. It is plausible that 
ERRα limits the bioavailability of oxygen in the lumen of the colon by promoting FAO. This hypothesis is consist-
ent with our results showing a downregulation of lipid metabolism genes in the colonocytes of Esrra−/− mice and 
an expansion of Proteobacteria. Furthermore, we observed a dramatic depletion of Akkermansia in Esrra−/− mice 
upon induction of colitis. Akkermansia utilises mucin as an energy source and releases metabolic by-products 
including SCFA, e.g. butyrate, among other factors for neighbouring gut  symbionts51. Butyrate is catabolized by 
colonic epithelial cells and provides the bulk of intestinal energy demand, thus, is important in the maintenance 
Figure 5.  The ERRα-dependent colon and IEC transcriptomes in colitis. (a) Volcano plot of RNA sequencing 
data obtained from DEseq2 analysis of the colon transcriptome of WT or Esrra−/− mice on day 8 post-DSS. 
Genes that are significantly differentially expressed (FDR < 0.1) are highlighted in red. Data represent 4 mice/
genotype. Volcano plots were generated using DEseq2 (v.1.28.1, https:// bioco nduct or. org/) in R (version 3.5, 
https:// cran.r- proje ct. org/) with packages ggplot2 (v.3.3.3). (b) Heatmap of upregulated (red) or downregulated 
(blue) genes in the colon of WT or Esrra−/− mice on day 8 following DSS treatment. Heatmaps were generated 
using the online version of Morpheus from the Broad Institute (https:// softw are. broad insti tute. org/ morph eus/). 
(c) Schematic representation of the experimental procedure of DSS-induced colitis following acute inhibition of 
ERRα. WT mice were either pre-treated with the ERRα inverse agonist C29 or vehicle control for 10 days then 
subjected to 3% DSS in their drinking water for 5 days, followed by regular drinking water for an additional 
3 days (days 5–8). (d) Representative photographs of colon and cecum from vehicle- or C29-treated WT 
mice on day 8 following 3% DSS treatment. (e) Colon length of vehicle (n = 6) or C29 (n = 9) treated WT mice 
after 3% DSS treatment. Statistical significance was performed using Student’s t-test, *p < 0.05. (f) Schematic 
representation of the experimental procedure of DSS-colitis following acute inhibition of ERRα. WT mice were 
either pre-treated with the ERRα inverse agonist C29 or vehicle control for 10 days then subjected to 3% DSS 
in their drinking water for 2 days. (g) Volcano plot of RNA sequencing data obtained from DEseq2 analysis of 
the IEC transcriptome of WT mice treated with C29 (n = 6) or vehicle control (n = 4). Significantly differentially 
expressed (FDR < 0.1) genes are depicted in red. Volcano plots were generated using DEseq2 (v.1.28.1, https:// 
bioco nduct or. org/) in R (version 3.5, https:// cran.r- proje ct. org/) with packages ggplot2 (v.3.3.3). (h) Heatmap 
of upregulated (red) or downregulated (blue) genes in IECs isolated from mice injected with compound C29 
(n = 6) or vehicle control (n = 4). Heatmaps were generated using the online version of Morpheus from the 
Broad Institute (https:// softw are. broad insti tute. org/ morph eus/). (i) Schematic illustration of metabolic genes 
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of colonocyte survival and mucosal  health52. Indeed, animals exhibited severe signs of experimental colitis when 
butyrate oxidation was  inhibited53. Accordingly, a decrease in Akkermansia read counts in Esrra−/− mice might 
contribute to the disruption of intestinal homeostasis by limiting butyrate production and availability.
The colon transcriptome of mice, at colitis endpoint, might not reflect direct functions of ERRα in intestinal 
homeostasis, as it can be affected by the inflammatory environment. Nonetheless, such analysis confirmed 
the heightened inflammatory pathology observed in Esrra−/− mice. Several IBD-implicated genes were identi-
fied to be DE in Esrra−/− mice. For instance, Ccl20, which encodes the sole ligand of CCR6, was upregulated 
in Esrra−/− mice. This chemokine is involved in lymphocyte trafficking and chronic intestinal  inflammation54. 
Consistently, Ccr6−/− mice have been reported to be less susceptible to DSS  colitis55. Our results show that Ndufa4 
that encodes a subunit of complex I of the respiratory chain was downregulated in DSS-treated Esrra−/− mice. It 
has been previously demonstrated that Ndufa4 dysregulation leads to impairment of mitochondrial respiration 
and the generation of  ROS56, which further fuels the inflammatory vicious cycle.
By inhibiting ERRα acutely with the inverse agonist  C2936, we aimed to abolish ERRα activity at an early 
time point in the DSS treatment regimen to explore causal mechanisms. This analysis highlighted an important 
role of ERRα-transcriptional targets involved in lipid energy metabolism (Fig. 5i). Apoc3 underwent the largest 
decrease in gene expression by C29. It has been previously shown that IEC-specific deletion of Apoc3 resulted in 
increased susceptibility to acute  colitis57, and expression of this gene is significantly reduced in IBD  patients37. 
More recently, it was demonstrated that ApoC-III-containing lipoproteins regulate intestinal immune toler-
ance through Tregs and IL-1058. Downregulation of Apoc3 in C29-treated mice might thus lead to impaired 
immune tolerance. The apoa1 gene is similarly downregulated by C29 in our experiments. ApoA-I, the main 
component of high-density lipoprotein (HDL), is anti-inflammatory. In enterocytes, HDL and apoA-I supress 
NF-κB-dependent induction of proinflammatory cytokines, and apoA-I null mice were previously reported to 
be susceptible to  colitis59. ApoA-I regulates lipid transport in the  intestine60 and is required to maintain IEC 
 TJ44. The Scd1 gene, which encodes an enzyme involved in the synthesis of oleic acid, was also downregulated 
following acute inhibition of ERRα in our experiments. Consistently, previous studies have shown that Scd1 
Figure 6.  Model illustrating the impact of ERRα-deficiency in experimental colitis. (a) The colon of a WT 
or an ERRα-deficient condition in experimental colitis. ERRα-deficiency results in a reduction in microbiota 
α-diversity, a collapse of bacteria associated with a healthy gut such as Akkermansia and an increase in 
Proteobacteria. This is accompanied by heightened epithelial tissue damage and erosion and an exacerbated 
intestinal inflammation characterized by increased immune infiltrates (neutrophils, T-lymphocytes) and 
inflammatory mediators (IL-6 and iNOS). IBD-implicated genes downregulated by ERRα inhibition are shown.
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deletion from the intestinal epithelium led to increased gut inflammation, a phenotype that could be rescued by 
dietary supplementation of oleic  acid61.
Additional C29-modulated genes included genes involved in immunity, blood coagulation, amino acid 
metabolism, protein transport, cell adhesion and spreading, and RNA synthesis. A reduction of Polymeric 
immunoglobulin receptor (Pigr) gene expression was observed following acute inhibition of ERRα. Interestingly, 
Pigr downregulation is a biomarker of CD  severity62. We show that Slc38a4, which encodes an organic solute 
carrier known to transport amino acids, was also downregulated by C29, consistent with previous findings in 
IBD  patients63. The C4b gene, involved in the classical complement activation pathway, has a critical role in 
maintaining tissue homeostasis through microbial elimination. C4b genes were previously linked to pediatric IBD 
and their deficiency was shown to increase susceptibility to  infections64. Serpinc1, Serpine1, and Plg, regulators 
of the blood coagulation cascade and necessary for mucosal  healing65, were downregulated by C29. Vtn has also 
been implicated in mucosal healing in the recovery phase of DSS-colitis66. Serpina1a, which encodes alpha-1 
antitrypsin, is known to exert an anti-inflammatory role by neutralizing neutrophil elastase. Previous studies 
have demonstrated elevated elastase activity in patients with IBD and experimental models of  colitis67,68. This is 
consistent with increased neutrophilic infiltrates shown in our data. Overall, the biological processes regulated 
by ERRα may act in synergy to protect the intestine and counter colitis (Fig. 6).
Consistent with our findings in this manuscript showing that genetic disruption of ERRα enhances colitis 
pathology in a murine model, ESRRA encoding human ERRα was recently found to be downregulated in IBD 
by the PROTECT study, which examined 428 treatment naïve UC patients and identified a core rectal UC gene 
expression  signature69. Among the DE genes, ESRRA was significantly downregulated in UC compared to non-
IBD controls (p = 1.10E−09), and gene set enrichment analysis (GSEA) of the altered genes in UC revealed a 
significant enrichment of genes regulated by ERRα, specifically in  IECs69. Importantly, this study pointed to 
mitochondriopathy and decreased aerobic tricarboxylic acid (TCA) cycle and metabolic functions (processes 
regulated by ERRα) as key features of UC. In contrast to IBD, colonic ERRα expression is upregulated in colorectal 
cancer (CRC) and is associated with poor disease  prognosis70,71. ERRα may thus be considered as a double-edge 
sword; it protects the intestine by promoting colonocytes survival and inducing compensatory proliferation after 
injury. On the other hand, its overexpression might exacerbate these processes leading to CRC.
In summary, this study reports a critical role of ERRα in the intestinal epithelium, validating it as a potential 
therapeutic target for clinical intervention in IBD.
Materials and methods
Animal strains. WT and ERRα-deficient (Esrra−/−) mice on a C57B1/6J background were bred and main-
tained at the McGill Comparative Medicine and Resources Centre. Esrra−/− mice were generated as previously 
described and were maintained by  crossbreeding72. All animals used were 8–12 weeks old male mice housed 
under pathogen-free conditions and were fed standard laboratory chow. The WT and Esrra−/− mouse colonies 
were generated from littermate parents. For most DSS experiments, including the bone marrow chimera experi-
ments, mice of the two genotypes were co-housed for 2 weeks prior to DSS treatment to normalize potential dif-
ferences in their microbiota. All experiments were approved by, and performed under guidelines, of the animal 
ethics committee of McGill University (Canada). This study is reported in accordance with ARRIVE guidelines.
Experimental colitis. Acute experimental colitis was induced by administering 3% (w/v) DSS (36,000–
50,000 kDa, MP Biomedicals Cat#160110) in the drinking water for 5 days (the DSS solution was renewed every 
second day) and subsequently replaced with regular water for an additional 3 days to allow for recovery. For the 
survival experiments, 3% (w/v) DSS was administered continuously for 12 days. Disease activity index (DAI) 
scores were based on a combined score for body weight loss, stool consistency, and visual rectal bleeding ranging 
from 0–7. For body weight loss, a score of 0–4 was given: 0, 0–5%; 1, 5–10%; 2, 10–15%; 3, 15–20%; and 4, > 20%. 
For stool consistency, a score of 0–3 was given: 0, normal; 1, mild diarrhea; and 2, severe diarrhea. A score of 0 or 
1 was given for the visual absence or presence, respectively, of rectal bleeding. For all experiments, we processed 
the colons following a defined dissection protocol applied to all mice, as follows: the 1st cm from the anal verge is 
discard, the 2nd cm for RNA extraction, the 3rd for protein extraction, the 4th for organ culture, and the remain-
ing tissue (~ 2–3 cm) is used for histology.
Bone marrow chimera. C57BL/6 and Esrra−/− mice were lethally irradiated with 450 rads twice in a 3-h 
interval using an X-ray RS-2000 Biological irradiator. Lethally irradiated mice were i.v. injected with  107 bone 
marrow cells after red blood cell depletion from indicated donors. Mice received 50 mg/mL enrofloxacin (Bay-
tril) in their drinking water 3 days before the irradiation and for 3 weeks post-irradiation. 8 weeks post bone 
marrow transplant, engraftment was verified by FACS staining and was confirmed as > 90% in recipient mice.
Acute inhibition of ERRα. C57BL/6 WT mice were i.p. injected daily for 10 days with vehicle or 10 mg/
kg of the ERRα inverse agonist compound 29 (C29)36 (Omegachem Inc.) in Ringer’s solution (containing 5.2% 
polyethylene glycol and 5.2% tween 80) prior to start of the DSS experiments and continued until the end of the 
experiments.
Isolation of intestinal epithelial cells. To isolate the IECs, colons were washed with cold PBS (Wisent, 
Cat#311-425-CL), cut into small pieces in RPMI (Wisent, Cat.350-000-CL) containing 5 mM EDTA (Fisher, 
Cat.BP2482-500), 3% FBS (Wisent, Cat# 350-000-CL), and DTT (Fisher, Cat.BP172-5) and placed in a shaking 
(170 RPM) incubator for 45 min at 37 °C. Following filtration in 100 μM strainers (Fisher, Cat.#10282631), the 
supernatant was centrifuged at 4 °C at 1500 rpm, and cells were resuspended in 30% (vol/vol) Percoll (Sigma, 
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Cat#P4937-100ML). The cells were spun again at 4  °C and the top layer isolated and resuspended in fresh 
RPMI (Wisent, Cat.350-000-CL). Centrifugation was repeated and RNA was extracted from pelleted cells using 
miRNeasy kit (Qiagen, Cat. # 217004) with RNase-free DNase Set (Qiagen, Cat. #79254).
Hematoxylin and Eosin (H&E) staining and immunofluorescence. Pieces of 1  cm2 of colon tissue 
were paraffin embedded following an overnight fixation in 10% buffered formalin. Sections (4 μm thick) were 
cut onto glass slides and stained with H&E. Images were captured using a ScanScope XT digital scanner and ana-
lyzed with the ImageScope software. Intestinal tissue damage and erosion were quantified by dividing the length 
of healthy, damaged or fully eroded sections by that of the full colon. For immunofluorescence, tissue sections 
were rehydrated by sequential incubation in ethanol solutions of different concentrations (100%, 90%, 70%, 50%; 
5 min each). For antigen retrieval, the slides were incubated in 0.1 M citrate buffer (pH 6.0) at 95 °C for 15 min. 
For permeabilization, the slides were next incubated in 0.25% Triton X-100 for 20 min at room temperature. 
For TUNEL staining, Click-iT TUNEL Alexa Fluor 647 (Invitrogen, Cat# C10247) was used according to the 
manufacturer’s instructions. Prior to incubation with primary antibodies, the slides were incubated in a solution 
of 10% FBS, 3% BSA blocking solution for 30 min at 37 °C. Primary antibodies diluted in a PBS solution with 
3% BSA were used for overnight incubation of slides at room temperature. The following antibodies were used: 
PCNA (Abcam, Cat# AB2426; RRID:AB_303062), cleaved caspase-3 (R&D Cat# AF835; RRID:AB_2243952), 
E-cadherin (BD Bioscience Cat# 610182; RRID:AB_397581), F4/80 (Abcam, Cat #ab6640; RRID:AB_1140040), 
Gr-1 (BD, Cat #557661; RRID:AB_396775), CD19 (eBioscience, Cat# 12-0191-81; RRID:AB_465577), CD3 
(eBioscience, Cat# 45-0031-82; RRID:AB_906226), Ly6G (Abcam, Cat #ab210204) and Muc2 (Santa Cruz Bio-
technology, Cat#sc-15334; RRID:AB_2146667). The slides were then washed with PBS and incubated with sec-
ondary antibodies for 1 h at room temperature. The secondary antibodies were conjugated with Alexa Fluor 488, 
594 or 647 (Molecular Probe). After washing with PBS, Hoechst 33342 (Invitrogen, Cat# H3570) staining was 
added. A Zeiss Axioscope microscope with its AxioVision software (version 4.9.1) and a high-resolution Axi-
oCam (Carl Zeiss Microscopy) were used for image acquisition at the McGill University Life Sciences Complex 
Advanced BioImaging Facility (ABIF). Image processing was performed using ImageJ 1.46 (National Institute 
of Health) on epifluorescence images after background clearance using the ‘BG subtraction from ROI’ plugin. 
Staining-positive cells were counted manually and quantified by crypt area  (mm2).
Western blot. 1  cm2 of colon tissue was dissected, washed in PBS and homogenized in complete buffer 
B150 (20 mM Tris–HCl pH 8.0, 150 mM KCl, 10% glycerol, 5 mM MgCl2, and 0.1% NP40) containing pro-
tease and phosphatase inhibitors (Roche Applied Science, Cat# 11836153001 and Sigma Cat# S7920, 71768, 
G6376). Proteins were migrated on an SDS-PAGE gel and transferred to a nitrocellulose membrane. Blots were 
incubated with primary antibodies against cleaved caspase-3 (Cell Signaling Cat# 9661; RRID:AB_2341188), 
anti-RIPK1 phospho-S166 (Cell Signaling Cat# 31122; RRID:AB_2799000), and β-actin (Sigma, Cat# A1978; 
RRID:AB_476744), followed by corresponding species secondary antibodies. Uncropped images of the western 
blots are shown in Supplementary Fig. 2.
RNA sequencing and analysis. 1  cm2 of colon tissue was dissected and washed in PBS. mRNA was 
extracted from total colon or purified IEC with the miRNeasy kit (Qiagen Cat. # 217004). Assessment of RNA 
quality and quantity was performed using Agilent Bioanalyzer 2100. 1 μg RNA was used for RNA sequencing 
at Novogene Corporation Inc, Beijing, China. Between 50 and 66 million raw reads were generated from each 
library. Bioconductor DEseq2 package (v.1.24) was used to calculate differential gene expression. Fragments per 
kilobase million (FPKM) were log transformed and normalized. R packages ggplot2 was used for the generation 
of the volcano plots. Heatmaps were generated using the online version of Morpheus from the Broad Institute 
(https:// softw are. broad insti tute. org/ morph eus/). Benjamini and Hochberg correction for multiple comparisons 
(at least one sample’s FPKM ≥ 1) was used for statistical analysis with an FDR-adjusted p-value of 0.1 for the 
heatmaps or 0.05 for the volcano plots.
Microbiota DNA sequencing and analysis. Fecal DNA was collected in 1.5 ml eppendorf tubes (Fish-
erbrand) and stored at − 80 °C until preparation. Total DNA was extracted using QIAmp PowerFecal DNA Kit 
(Cat#:12830-50) according to the manufacturer’s instructions (QIAmp DNA Stool Handbook 08/2017). DNA 
concentrations were measured with a NanoDrop Spectrometer and stored at −  80  °C. Samples (48 total) of 
gDNA (10  μg/μl) were sequenced at Genome Quebec, according to their protocol provided here. DNA was 
amplified using primer pair 341F (CCT ACG GGNGGC WGC AG) and 805R (GAC TAC HVGGG TAT CTA ATC 
C) from Illumina’s 16S library with sample-specific barcodes. These amplify the 16S V4 variable region of the 
rRNA gene. For the 48 samples, a total of 5,153,394 reads, 2,576,697,000 bases, with an average quality of 36 
was obtained. The 464 bp PCR products were sequenced on MiSeq PE250 Illumina platform (Illumina Inc., San 
Diego, CA, USA) generating two FASTQ files per sample. Paired reads from MiSeq were trimmed of primers, 
filtered for high quality (phred score > 30) and merged. Reads with at least 1 “N” were discarded, and sequence 
chimeras were removed using Uchime2 against the "Gold"  database73. Taxonomic affiliation of 16S sequencing 
data was performed using the QIIME2 pipeline. Quality filtered sequences from pre-processing were denoised 
and underwent further QC filtering by DADA2 to create representative sequences for each amplicon sequence 
variant (AVS), and a feature table which indicates quantity of reads of each AVS observed in each sample. Feature 
classifier was used to assign likely taxonomies to reads through a model pretrained by a Naive Bayes classifier 
on GreenGenes database with 99% OTUs. Data were rarefied using the samples with the smallest number of 
reads and then subjected to alpha-diversity analysis employing Faith’s phylogenetic diversity. Kruskal–Wallis 
was calculated between all groups together and for pairwise comparisons. To find significant differences at the 
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genera taxonomy level, ANCOM volcano plots were drawn to identify features that are differentially abundant 
across sample  groups74.
Quantitative real‑time PCR. For qRT-PCR, 1  cm2 of mouse colon tissue was dissected and washed in 
PBS. Total RNA was isolated using the RNeasy Mini Kit (Qiagen). cDNA was made from 1 μg of RNA by reverse 
transcription with Random Primer Mix, dNTPs, 5X ProtoScript II RT Reaction buffer, DTT, RNAse inhibitor 
and ProtoScript II Reverse Transcriptase (NEB). cDNA was amplified by qRT-PCR using SYBR Green Master 
Mix (Roche) and a LightCycler 480 instrument (Roche) with specific primers. Relative quantification was nor-
malized to RPLP0 expression using the  2−ΔΔCT method. Specific primers used were:
Esrra:
forward 5′-CCA GAG GTG GAC CCT TTG CCT TTC -3′
reverse 5′-CAC CAG CAG ATG CGA CAC CAGAG-3′
iNOS:
forward 5′-GTG AAG AAA ACC CCT TGT GCTG-3′
reverse 5′-CTC ACA TAC TGT GGA CGG GTCG-3′
TNFa:
forward 5′-CTT CCA GAA CTC CAG GCG GTGC-3′
reverse 5′- CAT AGA ACT GAT GAG AGG GAGGC-3′
IL-6:
forward 5′-AAG TGC ATC ATC GTT GTT CA-3′
reverse 5′-GAG GAT ACC ACT CCC AAC AG-3′
RPLP0:
forward 5′-GCA GCA GAT CCG CAT GTC GCT CCG -3′
reverse 5′-GAG CTG GCA CAG TGA CCT CAC ACG G-3′.
Statistical analysis. Data is represented as mean ± standard error of the mean. Two-tailed Student’s t test 
and ANOVA were used for evaluating statistical significance between groups. *P < 0.05; **P < 0.01; ***P < 0.001; 
****P < 0.0001; N.S., not significant. The ANCOM test was used to identify microbiota features that are differen-
tially abundant between genotypes.
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